Therapeutic Solutions International Returns to Fully Reporting Status with SEC
July 06, 2017 09:22 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - July 06, 2017) - Therapeutic Solutions International, Inc. (OTC PINK: TSOI), announced today that it has recently completed all of its regulatory filings to return to...
Therapeutic Solutions Subsidiary, SandBox Dental Labs, files 510(k) with FDA
June 26, 2017 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - June 26, 2017) - Therapeutics Solutions International, Inc. (OTC PINK: TSOI) announced today that their majority-owned subsidiary, SandBox Dental Labs, Inc., has filed a...
Therapeutic Solutions International Announces Exclusive Patent License Agreement with Subsidiary Emvolio, Inc.
June 12, 2017 08:55 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - June 12, 2017) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today an exclusive licensing agreement with its subsidiary, Emvolio, Inc.The...
Therapeutic Solutions files Patent on Methods of Re-Activating Dormant Memory Cells with Anticancer Activity
June 05, 2017 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - June 05, 2017) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a new patent for a biologic product called "MemoryMune".The...
Therapeutic Solutions International Announces Exclusive Patent License Agreement with Subsidiary Emvolio, Inc.
June 01, 2017 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - June 01, 2017) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today an exclusive licensing agreement with its subsidiary Emvolio, Inc.The...
Therapeutic Solutions files new Patent on Augmentation of Anti-Tumor Immunity by Mifepristone and Analogues Thereof
May 22, 2017 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - May 22, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a patent covering a repurposing of the FDA cleared drug...
Therapeutic Solutions International Announces Exclusive Patent License Agreement to innaMune with its Subsidiary Emvolio, Inc.
May 18, 2017 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - May 18, 2017) - Therapeutics Solutions International, Inc. (OTC PINK: TSOI) announced today an exclusive licensing agreement with its subsidiary, Emvolio, Inc. The...
Therapeutic Solutions files Patent on Blood Derived Innate Immune System Stimulator
May 16, 2017 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - May 16, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a patent for a novel blood derived stimulator of innate immune...
Therapeutic Solutions International Announces Exclusive Patent License Agreement with its Subsidiary Emvolio, Inc.
May 10, 2017 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - May 10, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today an exclusive licensing agreement with its subsidiary Emvolio, Inc. The...
Therapeutic Solutions files new Patent on Targeting the Tumor Microenvironment through Nutraceutical Based Immunoadjuvants
May 09, 2017 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - May 09, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a patent for a nutraceutical product called "Cancer Metabolic...